Zeke Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.76M | Sell |
24,908
-1,737
| -7% | -$178K | 0.18% | 57 |
|
|
2022
Q3 | $2.29M | Sell |
26,645
-4
| -0% | -$357 | 0.17% | 62 |
|
|
2022
Q2 | $2.43M | Sell |
26,649
-3,172
| -11% | -$281K | 0.16% | 66 |
|
|
2022
Q1 | $2.45M | Buy |
29,821
+14,065
| +89% | +$1.11M | 0.12% | 80 |
|
|
2021
Q4 | $1.21M | Sell |
15,756
-866
| -5% | -$69K | 0.07% | 85 |
|
|
2021
Q3 | $1.25M | Buy |
16,622
+758
| +5% | +$57.6K | 0.07% | 85 |
|
|
2021
Q2 | $1.23M | Sell |
15,864
-845
| -5% | -$62.9K | 0.08% | 86 |
|
|
2021
Q1 | $1.23M | Sell |
16,709
-4,207
| -20% | -$310K | 0.09% | 76 |
|
|
2020
Q4 | $1.63M | Buy |
20,916
+3,977
| +23% | +$304K | 0.13% | 60 |
|
|
2020
Q3 | $1.34M | Sell |
16,939
-1,009
| -6% | -$79K | 0.15% | 47 |
|
|
2020
Q2 | $1.32M | Sell |
17,948
-4,766
| -21% | -$359K | 0.26% | 44 |
|
|
2020
Q1 | $1.67M | Sell |
22,714
-2,335
| -9% | -$184K | 0.47% | 27 |
|
|
2019
Q4 | $2.17M | Sell |
25,049
-1,466
| -6% | -$120K | 0.18% | 105 |
|
|
2019
Q3 | $2.13M | Buy |
26,515
+3,767
| +17% | +$302K | 0.19% | 94 |
|
|
2019
Q2 | $1.82M | Buy |
22,748
+401
| +2% | +$30.7K | 0.17% | 105 |
|
|
2019
Q1 | $1.77M | Sell |
22,347
-4,057
| -15% | -$303K | 0.16% | 109 |
|
|
2018
Q4 | $1.93M | Sell |
26,404
-75,588
| -74% | -$5.34M | 0.18% | 94 |
|
|
2018
Q3 | $6.9M | Sell |
101,992
-628
| -0.6% | -$40K | 0.56% | 32 |
|
|
2018
Q2 | $5.94M | Buy |
102,620
+11,801
| +13% | +$666K | 0.55% | 38 |
|
|
2018
Q1 | $4.72M | Buy |
90,819
+13,914
| +18% | +$751K | 0.44% | 44 |
|
|
2017
Q4 | $4.13M | Buy |
76,905
+497
| +0.7% | +$27.6K | 0.43% | 39 |
|
|
2017
Q3 | $4.67M | Buy |
76,408
+53,429
| +233% | +$3.24M | 0.64% | 20 |
|
|
2017
Q2 | $1.41M | Buy |
22,979
+2,525
| +12% | +$154K | 0.27% | 56 |
|
|
2017
Q1 | $1.24M | Sell |
20,454
-2,967
| -13% | -$180K | 0.25% | 50 |
|
|
2016
Q4 | $1.32M | Buy |
23,421
+11,712
| +100% | +$685K | 0.36% | 39 |
|
|
2016
Q3 | $679K | Buy |
+11,709
| New | +$685K | 0.31% | 23 |
|
|
2016
Q1 | – | Sell |
-4,765
| Closed | -$240K | – | 39 |
|
|
2015
Q4 | $240K | Sell |
4,765
-1,746
| -27% | -$88K | 0.21% | 35 |
|
|
2015
Q3 | $307K | Buy |
6,511
+269
| +4% | +$14.3K | 0.2% | 33 |
|
|
2015
Q2 | $339K | Sell |
6,242
-3,990
| -39% | -$224K | 0.27% | 33 |
|
|
2015
Q1 | $561K | Sell |
10,232
-179
| -2% | -$10.1K | 0.44% | 28 |
|
|
2014
Q4 | $564K | Buy |
10,411
+2,831
| +37% | +$158K | 0.44% | 32 |
|
|
2014
Q3 | $429K | Hold |
7,580
| – | – | 0.39% | 37 |
|
|
2014
Q2 | $418K | Buy |
7,580
+139
| +2% | +$7.58K | 0.34% | 41 |
|
|
2014
Q1 | $403K | Hold |
7,441
| – | – | 0.35% | 36 |
|
|
2013
Q4 | $355K | Hold |
7,441
| – | – | 0.33% | 40 |
|
|
2013
Q3 | $338K | Buy |
7,441
+3,144
| +73% | +$144K | 0.32% | 39 |
|
|
2013
Q2 | $190K | Buy |
+4,297
| New | +$192K | 0.16% | 44 |
|
Other funds holding MRK
AWA
Zeke Capital Advisors's MRK Position: Q4 2022 in Review
Zeke Capital Advisors reduced its Merck (MRK) stake by 6.5% in Q4 2022, selling an estimated $178K and leaving 24,908 shares worth $2.76M. The position accounts for 0.18% of the portfolio, ranked #57.
Zeke Capital Advisors first reported a position in MRK in Q2 2013 and has held it in 37 quarters since. The position peaked at $6.9M in Q3 2018. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Zeke Capital Advisors held 24,908 shares of Merck worth $2.76M as of Q4 2022.
- Zeke Capital Advisors sold 1,737 Merck shares in Q4 2022, an estimated $178K.
- Merck made up 0.18% of Zeke Capital Advisors's portfolio in Q4 2022, its #57 holding.
- Zeke Capital Advisors first reported a position in Merck in Q2 2013 and has held it in 37 quarters since.
- Zeke Capital Advisors's Merck position peaked at $6.9M in Q3 2018.
- 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.